RxDoctor Payments Data

Jay Klarsfeld, MD

Otolaryngology · Danbury, CTNPI 1215932660

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,755 of the $4,010 with a category attached, or 68.7%. 19 manufacturers reported payments, led by Aerin Medical Inc. at 59.8% of the total. 2025 is the largest year on record at $2,658, more than ten times the $104 reported in 2019.

$4,010in general payments, 2019–2025

Across 80 payments — averaging $50.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aerin Medical Inc.$2K
  • GSK$385
  • Regeneron Healthcare Solutions, Inc.$229
  • Intersect ENT, Inc.$192
  • Checkpoint Surgical, Inc$170
  • Davol Inc.$119
  • plus $520 from 13 others

What the payments were for

  • Travel & lodging$1,25431%
  • Food & beverage$2,75569%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,010 in reported general payments places this provider in the 75th percentile of 119 otolaryngology providers in Connecticut.

See all otolaryngology providers in Connecticut

Medicare billing

Part B allowed, 2024
$210,560
Medicare patients
491
Services billed
1,420

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth25$2,537
Methylprednisolone97$697
Fluticasone Propionate31$449
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav49$404
CefuroximeCefuroxime Axetil11$168
Pantoprazole Sodium29$166
Azithromycin38$161
Cefadroxil20$152
Mometasone Furoate11$108
Prednisone22$92
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen14$57
Lorazepam15$14

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Danbury

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →